New From Kineticos

Press Release

May 30, 2023

eXmoor pharma Completes $35 Million Series A

New GMP facility to complete eXmoor’s transition from consultancy to one-stop global cell and gene therapy partner Bristol, UK |…

Press Release

March 28, 2023

EnteroBiotix Initiates Phase 2 Study

IMPuLSE Intestinal Microbiota Product in Liver Cirrhosis and Encephalopathy GLASGOW, United Kingdom | March 28, 2023 – EnteroBiotix Limited (“EBX”),…

Press Release

November 30, 2022

Experic Closes $14 Million Series B Financing

Experic, a contract development and manufacturing organization (CDMO) and clinical supply services company serving the biopharmaceutical industry, today announced the…

Press Release

February 18, 2022

Recipharm Acquires Arranta Bio

Recipharm, a leading global contract development and manufacturing organisation (CDMO), today announced the acquisition of Arranta Bio.

Press Release

January 7, 2022

Amylyx Pharmaceuticals Announces Pricing of Upsized Initial Public Offering of Common Stock

Media Coverage

December 2, 2021

Supporting Innovative Biotechs to Bring Cell and Gene Therapies to Market

Kineticos takes an immersive stance with their biotech engagements and investments, working closely in a collaborative effort with key leadership…

Press Release

September 8, 2021

EnteroBiotix secures $21.5M series A to advance microbiome drug pipeline

Press Release

April 28, 2021

Kineticos Announces Frank Lis as President and CEO of Kineticos Ventures

Kineticos announced today that Frank Lis has joined as President and Chief Executive Officer of Kineticos Ventures, a new subsidiary…

Press Release

February 24, 2021

Kineticos Disruptor Fund and Eos Advisory Form Partnership To Invest In Disruptive Life Science Companies in Scotland

St Andrews-based Eos Advisory has entered into a strategic partnership with Kineticos to co-invest in early-stage Scottish life sciences companies.…